Temozolomide enhances herpes simplex virus thymidine kinase/ganciclovir therapy of malignant glioma

Cancer Gene Therapy

Volumn 8, Issue 9, 2001, Pages 662-668

  Rainov, Nikolai G ^a,b   Fels, Carsten ^a   Droege, Jan Wilhelm ^a   Schäfer, Christoph ^a   Kramm, Christof M ^c   Chou, Ting Chao ^d  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Brain tumor; Ganciclovir; Glioblastoma; HSV tk; Temozolomide

Indexed keywords

GANCICLOVIR; TEMOZOLOMIDE; THYMIDINE KINASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TUMOR; CANCER SURVIVAL; CELL KILLING; CELL VIABILITY; DRUG EFFICACY; GENE THERAPY; GLIOBLASTOMA; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CELL DIVISION; DACARBAZINE; DRUG INTERACTIONS; DRUG SYNERGISM; GANCICLOVIR; GENE THERAPY; GLIOMA; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; SIMPLEXVIRUS; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

EID: 0034810796     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700355     Document Type: Article

References (34)

1. Brain cancer incidence, mortality and case survival: Observations from two Australian cancer registries
2. Patient age, histologic features and length of survival in patients with glioblastoma multiforme
3. The basis fort current treatment recommendations for malignant gliomas
4. Biology and treatment of malignant glioma
5. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
6. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy
7. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir
8. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
9. A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir
10. The "bystander effect": Tumour regression when a fraction of the tumour mass is genetically modified
11. A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy for previously untreated glioblastoma multiforme in adults
12. Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells
13. Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma
14. New treatment strategies for malignant gliomas
15. DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma
16. The Charing Cross Hospital experience with temozolomide in patients with gliomas
17. Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair
18. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene
19. Generalized equations for the analysis of inhibitions of Michaelis-Menten and higher-order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors
20. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
21. The median-effect principle and the combination index for quantitation of synergism and antagonism
22. Drug combinations: From laboratory to practice
23. Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: A rational approach to clinical protocol design
24. Kinetic studies of herpes simplex virus type 1-encoded thymidine and thymidylate kinase, a multifunctional enzyme
25. Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies
26. Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections
27. Antitumour imidazotetrazines: Part 37. Conjugation of the DNA major-groove alkylating imidazotetrazine mitozolomide to peptide motifs recognizing the minor groove
28. O(6)-benzylguanine enhances the in vitro immunotoxic activity of temozolomide on natural or antigen-dependent immunity
29. Intracellular localization and intercellular heterogeneity of the human DNA repair protein O(6)-methylguanine-DNA methyltransferase
30. Multimodal cancer treatment mediated by a replicating oncolytic virus that delivers the oxazaphosphorine/rat cytochrome P450 2B1 and ganciclovir/herpes simplex virus thymidine kinase gene therapies
31. Acyclic guanosine analogs inhibit DNA polymerases alpha, delta, and epsilon with very different potencies and have unique mechanisms of action
32. Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignancies